361 CAPITAL LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
361 CAPITAL LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2020$1,074,000
-13.2%
18,555
-19.2%
0.49%
+42.3%
Q4 2019$1,238,000
+2.6%
22,956
-3.9%
0.34%
+63.3%
Q1 2019$1,207,000
-21.8%
23,895
-21.8%
0.21%
-40.0%
Q2 2018$1,543,000
-0.8%
30,556
+3.4%
0.35%
-9.1%
Q1 2018$1,556,000
-36.4%
29,547
-43.9%
0.38%
-36.5%
Q4 2017$2,447,000
+1105.4%
52,662
+948.0%
0.61%
+1453.8%
Q3 2017$203,0005,0250.04%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders